Comparison of Outcome Between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation

被引：0
|
作者：
Kim, S. [1 ]
Lim, M. [1 ]
Kwon, J. [1 ]
Jeong, E. [1 ]
Yang, J. [1 ]
Kim, K. [1 ]
Lee, K. [1 ]
Lee, O. [1 ]
Joh, J. [1 ]
机构：
[1] Samsung Med Ctr, Transplantat, Seoul, South Korea
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A-4
引用
下载
收藏
页码：904 / 904
页数：1
相关论文
共 50 条
  • [21] The Role of low-dose Anti-thymocyte Globulin in Matched Sibling Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies
    Liu, Daihong
    Dou, Liping
    Wang, Lu
    Li, Fei
    Wang, Lijun
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 364 - 364
  • [22] EARLY OUTCOMES POST RENAL TRANSPLANTATION IN LOW AND MODERATE IMMUNOLOGIC RISK RECIPIENTS FOLLOWING BASILIXIMAB OR RABBIT ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY
    Salehi, T.
    Clayton, P. A.
    NEPHROLOGY, 2020, 25 : 80 - 80
  • [23] Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation
    Alloway, Rita R.
    Woodle, E. Steve
    Abramowicz, Daniel
    Segev, Dorry L.
    Castan, Remi
    Ilsley, Jillian N.
    Jeschke, Kari
    Somerville, Kenneth Troy
    Brennan, Daniel C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (08) : 2252 - 2261
  • [24] Comparison of basiliximab to rabbit anti-thymocyte globulin induction therapy in African American kidney transplant recipients.
    Mogilishetty, G
    Barone, G
    Kumar, J
    Rekhi, A
    Abul-Ezz, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 773A - 773A
  • [25] Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation
    Ayumu Ito
    Shigehisa Kitano
    Kinuko Tajima
    Youngji Kim
    Takashi Tanaka
    Yoshihiro Inamoto
    Sung-Won Kim
    Noboru Yamamoto
    Takahiro Fukuda
    Shinichiro Okamoto
    International Journal of Hematology, 2020, 111 : 120 - 130
  • [26] Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation
    Ito, Ayumu
    Kitano, Shigehisa
    Tajima, Kinuko
    Kim, Youngji
    Tanaka, Takashi
    Inamoto, Yoshihiro
    Kim, Sung-Won
    Yamamoto, Noboru
    Fukuda, Takahiro
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (01) : 120 - 130
  • [27] LONG-TERM OUTCOME OF INDUCTION IMMUNOSUPPRESSION USING ANTI-THYMOCYTE GLOBULIN VERSUS BASILIXIMAB IN KIDNEY TRANSPLANTATION
    Mohamed, Taher F.
    Ehab, Wafa W.
    Yasser, Moniem El Hendy
    Tamer, Goda M.
    Mohamed, Mashaly
    Ahmed, Denewar
    TRANSPLANT INTERNATIONAL, 2017, 30 : 562 - 563
  • [28] A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin
    Wang Wei
    Yin Hang
    Li Xiao-bei
    Hu Xiao-peng
    Yang Xiao-yong
    Liu Hang
    Ren Liang
    Wang Yong
    Zhang Xiao-dong
    CHINESE MEDICAL JOURNAL, 2012, 125 (06) : 1135 - 1140
  • [29] A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin
    WANG WeiYIN HangLI XiaobeiHU XiaopengYANG XiaoyongLIU HangREN Liang WANG Yong and ZHANG Xiaodong Department of UrologyBeijing ChaoYang HospitalCapital Medical UniversityBeijing China
    中华医学杂志(英文版), 2012, (06) : 1135 - 1140
  • [30] Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation
    Flaman, Flavia
    Zieroth, Shelley
    Rao, Vivek
    Ross, Heather
    Delgado, Diego H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (11): : 1358 - 1362
12345